- Home
- MOGU vs RDHL Comparison
MOGU vs RDHL Comparison
Compare MOGU & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- RDHL
- Stock Information
- Founded
- MOGU 2011
- RDHL 2009
- Country
- MOGU China
- RDHL Israel
- Employees
- MOGU N/A
- RDHL N/A
- Industry
- MOGU Business Services
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- RDHL Health Care
- Exchange
- MOGU Nasdaq
- RDHL Nasdaq
- Market Cap
- MOGU 19.8M
- RDHL 3.9M
- IPO Year
- MOGU 2018
- RDHL N/A
- Fundamental
- Price
- MOGU $4.48
- RDHL $1.70
- Analyst Decision
- MOGU
- RDHL
- Analyst Count
- MOGU 0
- RDHL 0
- Target Price
- MOGU N/A
- RDHL N/A
- AVG Volume (30 Days)
- MOGU 3.7M
- RDHL 43.2K
- Earning Date
- MOGU 07-21-2025
- RDHL 09-05-2025
- Dividend Yield
- MOGU N/A
- RDHL N/A
- EPS Growth
- MOGU N/A
- RDHL N/A
- EPS
- MOGU N/A
- RDHL N/A
- Revenue
- MOGU $19,462,964.00
- RDHL $9,550,000.00
- Revenue This Year
- MOGU N/A
- RDHL $381.91
- Revenue Next Year
- MOGU N/A
- RDHL N/A
- P/E Ratio
- MOGU N/A
- RDHL N/A
- Revenue Growth
- MOGU N/A
- RDHL 157.62
- 52 Week Low
- MOGU $1.83
- RDHL $1.06
- 52 Week High
- MOGU $8.10
- RDHL $11.07
- Technical
- Relative Strength Index (RSI)
- MOGU 69.30
- RDHL 63.39
- Support Level
- MOGU $4.10
- RDHL $1.47
- Resistance Level
- MOGU $5.50
- RDHL $1.71
- Average True Range (ATR)
- MOGU 0.60
- RDHL 0.09
- MACD
- MOGU 0.21
- RDHL 0.05
- Stochastic Oscillator
- MOGU 39.53
- RDHL 97.98
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.